NASHUA, N.H., Sept. 23, 2019 /PRNewswire/ — Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Closure (LAAC) System, will present data on the first human implants of its unique technology for the prevention of stroke in patients with atrial fibrillation (AFib) at the TCT 2019 meeting September 25, 2019 at 4:30pm. The study’s […]
Read MoreNews
Conformal is an innovative medical device developer dedicated to reducing stroke risk in patients with atrial fibrillation. A list of recent press releases can be found below.
We welcome inquiries about our technology and product pipeline. Click here to contact us.
Conformal Medical Announces First Human Use of Conformal LAA Seal for Stroke Prevention in US Feasibility Study
Nashua, NH – April 9, 2019 – Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, reports the first human use of its proprietary technology for the prevention of stroke in patients with atrial fibrillation (AFib). The case was performed by Robert Sommer, MD at New York-Presbyterian/Columbia University Medical Center […]
Read MoreConformal Medical Announces $9 million Series B Financing
Nashua, NH – December 3, 2018 – Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, has secured $9 million in Series B funding. Conformal is developing proprietary seal technology for the prevention of stroke in patients with atrial fibrillation (AFib). Over five million people in the United States have […]
Read More